Arthur Kavanaugh, MD, University of California, San Diego, Division of Rheumatology, Allergy, and Immunology, La Jolla, CA, United States; Phillip Mease, MD, Seattle Rheumatology Associates, Swedish Hospital Medical Center, Seattle, WA, United States; Anna Beutler, MD, Centocor, Inc., Malvern, PA, United States; Christian Antoni, MD, Friedrich-Alexander University, Erlangen, GermanyLe texte complet de cet article est disponible en PDF.
Dr. Kavanaugh has consulted and participated in clinical research sponsored by Centocor, Amgen, and Abbott Laboratories. Dr. Mease receives grant support for clinical trials and is a consultant for Centocor. Dr. Antoni is an investigator and consultant for infliximab at Centocor.
Studies have been funded by research grants from Centocor (IMPACT) or have been done by Centocor (IMPACT 2).